Cardiff Oncology, Inc. (CRDF) vs Seer, Inc. (SEER)
Cardiff Oncology, Inc. and Seer, Inc. are both Biotechnology companies. Cardiff Oncology, Inc. and Seer, Inc. are of similar size ($103.6M and $99.6M). Cardiff Oncology, Inc. grew revenue faster over the last twelve months: −6.79% against −12.7%. Seer, Inc. has the higher net margin (−478.1% vs −7,889.0%) and the lower return on invested capital (−60.8% vs 0.00%). Across the 17 metrics below, Seer, Inc. leads on 11 and Cardiff Oncology, Inc. on 6.
Valuation
Profitability
| Metric | CRDF | SEER | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 47.70% | 65.16% |
| Operating margin | (8,320.08%) | (498.19%) | 0.00% |
| Net margin | (7,888.98%) | (478.05%) | 0.00% |
| Free cash flow margin | (8,059.45%) | (309.34%) | 0.00% |
| Return on equity | (94.14%) | (26.45%) | (57.72%) |
| Return on assets | (70.89%) | (23.47%) | (49.22%) |
| Return on invested capital | 0.00% | (60.78%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack